
Releases
GeneDx Investors Face August Deadline in Securities Class Action
Investors who lost more than $100,000 in GeneDx Holdings Corp. stock between April 2025 and May 2026 have until August 3 to apply as lead plaintiffs in a pending class action lawsuit. The case, filed in the District of Connecticut, centers on allegations that the company withheld material financial information.



















